Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
As the spouse of an adult who has type 1 diabetes, I know the value of using a CGM. Just using the device gives her a sense of security and has increased her TIR immensely. However, with this technology there is an increased sense of responsibility, and there is never a time when she is not “in the know” and required to do something about it. These same feelings are often shared by children with type 1, and they have the added burden of a parent watching over them. This can become overwhelming when you add in the long future that they have with this constant “report card.”
This week one of our interns, Nour Salhab, has a great article on how best to optimize CGM use in young children while avoiding burnout.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
How many years can semaglutide add to your life?
Since DPP-4 plays a role in infection for some coronaviruses, there is increased interest in whether patients using DPP-4 inhibitors are at greater pneumonia risk.
CGM use in young children with type 1 diabetes has its benefits and challenges, according to their parents.
Did You Know: Almonds Can Reduce Depression Risk in T2D?
A bidirectional relationship is known to exist between T2DM and depression; depression increases the risk of the development of T2D, while T2D increases the risk of depression. An almond-rich diet with a low-carb diet (LCD) has been shown to reduce depression and glycometabolism in patients with T2D. According to a newly published study, the diet’s impact on the gut microbiota comes from its effect. Nuts, as part of LCD, have been shown to effectively improve glycosylated hemoglobin (HbA1c) levels and fasting blood glucose (FBG) in T2DM patients. The almond is the most consumed and studied nut. Its prebiotic properties have been shown to contribute to increased production of short-chain fatty acids (SCFAs) in the gut microbiome, promoting the secretion of glucagon-like peptide 1 (GLP-1), an essential regulator of microbiota-gut-brain signaling in health and stress-related psychiatric illnesses.
A randomized controlled trial was carried out to compare the effects of an almond rich low carb diet (a-LCD) with a low-fat diet (LFD). Forty-five participants with T2DM were enrolled, and the participants completed each dietary intervention for three months. The indicators for depression and biochemical indicators, including glycosylated hemoglobin (HbA1c), gut microbiota, and GLP-1 concentration, were assessed at the baseline and third month and compared between the two groups. The resulting data revealed a low carb diet significantly improved depression and HbA1c (p <0.01). What’s more, the GLP-1 concentration in the a-LCD group was higher than that in the LFD group (p <0.05). The results concluded that almonds are rich in dietary fiber, polyphenols, and unsaturated fatty acids that may be protective against the development of depression.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
Destiny Funchess, PharmD Candidate, Tougaloo College, South College School of Pharmacy
Aleksandra Kusic, PharmD Candidate, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences
Joan Prifti, PharmD. Candidate, LECOM College of Pharmacy
Destiny Reed, PharmD. Candidate, Florida A&M College of Pharmacy and Pharmaceutical Sciences
Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy
Peter Jay Won, Pharm.D. Candidate, University of South Florida, Taneja College of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com